Shanghai Haohai Biological Technology Co., Ltd. (Haohai Biotec) released its annual results announcement for the year ended 31 December 2025, proposing a final ordinary cash dividend of RMB0.60 per share.

The dividend remains subject to shareholder approval at an upcoming meeting, with the specific date yet to be announced. Key administrative dates—including the ex-dividend date, record date, book-closure period, and payment date—will be disclosed in due course.

For Hong Kong-registered shares, the dividend will be paid in Hong Kong dollars at an exchange rate to be announced. Computershare Hong Kong Investor Services Limited will serve as the share registrar for the distribution. Details regarding any applicable withholding tax will also be provided later.

The board composition at the time of the announcement includes four executive directors, three non-executive directors, and four independent non-executive directors.